CLINICAL_TRIALS
trial_result
· 2022-04-04
Clinical Trial Update: Ozone Therapy in Refractory Ischemic Heart Disease. [Phase 2, Phase 3]
Summary
A clinical trial update for ozone therapy in ischemic heart disease has been terminated after Phase 2/3 testing.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bernardino Clavo, MD, PhD | Conditions: Ischemic Heart Disease | Phase 2, Phase 3 | Status: TERMINATED